Best Practice Database Supports Bio-Pharma Product Launch

CHAPEL HILL, N.C., Sept. 11 Bio-Pharma executives areincreasingly finding value in the research products and services offered byBest Practices, LLC and in particular in use of the on-demand benchmarkrepository known as the Best Practice Database (www.BestPracticeDatabase.com).Although documents from the database may be accessed and downloadedindividually, many commercial and operations leaders have come to findoutstanding value in membership to the database which not only provides fullaccess to all content as needed, but also includes services such as newresearch alerts, invitations to participate in topical new studies and ongoingadvisory services to address research needs.

A series of six case study analogs recently published to the databasereview various aspects of product launch, providing unique perspectives forunderstanding the strategies and tactics utilized by top bio-pharma companiesto address commercial issues surrounding their products. One study, "CymbaltaCase Study: Successfully Entering a Crowded Market with a New Mechanism ofAction," reviews the strategy and tactics utilized by Eli Lilly for thedepression indicated product, Cymbalta, to successfully penetrate a crowdedmarket with a product having a new mechanism of action (MOA). Pharmaceuticalexecutives can use this study to gather insights into various tactics forsuccessfully launching a product with a new MOA into a challenging market.

For a complimentary summary from this case study, found in the BestPractice Database, "Cymbalta Case Study: Successfully Entering a CrowdedMarket with a New Mechanism of Action," click on the following link:http://www3.best-in-class.com/dr335.htm.

For more information on this study or the Best Practice Database, contactRobert Naylor at [email protected] or (919) 767-9244. Interestedparties may sign-up for a customized tour of the database via the followingURL: http://www3.best-in-class.com/dw212.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profoundprinciple that organizations can chart a course to superior economicperformance by studying the best business practices, operating tactics andwinning strategies of world-class companies. For more than 15 years, ourhighly credentialed research staff has conducted primary research exclusivelyfor our Fortune 500 client base.Key topic areas in the research include: -- Business Challenges Addressed -- Market Entry Strategy and Insights -- Use of Third-Party Expertise -- Influencing Key Opinion Leaders -- Tactics to Drive Success -- Focus on Product Efficacy and Safety -- Product Differentiation -- Leveraging Public Relations -- Benefits of Patient Education -- Diversification of Tactics -- Early Lifecycle Management -- Crafting a Durable Brand Promise -- Preparing the Market Through Education Metrics included in this report are: -- Product Lifecycle Timeline -- Messaging Strategy -- PR Strategy -- Market Revenues Over Time -- Market DTC Expenditures

SOURCE Best Practices, LLC

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...